USA - NASDAQ:TCON - US89237H3084 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to TCON. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-01 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-04-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-21 | JonesTrading | Downgrade | Buy -> Hold |
| 2023-08-15 | Baird | Maintains | Outperform -> Outperform |
| 2023-05-11 | Baird | Maintains | Outperform -> Outperform |
| 2023-05-11 | Maxim Group | Maintains | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-02-23 | Baird | Initiate | Outperform |
| 2021-06-04 | Alliance Global Partners | Initiate | Buy |
| 2021-04-16 | BTIG | Upgrade | Neutral -> Buy |
| 2021-04-01 | Jones Trading | Initiate | Buy |
9 analysts have analysed TCON and the average price target is 31.11 USD. This implies a price increase of 2075.52% is expected in the next year compared to the current price of 1.43.
The consensus rating for TRACON PHARMACEUTICALS INC (TCON) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.